Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Nexalin Therapy for the Treatment of Depressive Symptoms
Phase 2
Completed
- Conditions
- Depression
- Interventions
- Device: Nexalin 1.3mA DeviceDevice: Nexalin 15mA deviceDrug: placebo device and Citalopram
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2008-10-17
- Lead Sponsor
- Kalaco Scientific, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT00774813
- Locations
- 🇷🇺
Leningrad Regional Center of Addiction, Leningrad, Vsevolozhsky District, Russian Federation
🇷🇺St. Petersburg City Center of Neuroses, St. Petersburg, Russian Federation
News
No news found